Morgan Stanley Reiterates Equal-Weight on Accolade, Maintains $14 Price Target
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst Ricky Goldwasser has reiterated an Equal-Weight rating on Accolade (NASDAQ:ACCD) and maintained a $14 price target.
June 22, 2023 | 12:24 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Morgan Stanley analyst Ricky Goldwasser reiterated an Equal-Weight rating on Accolade (NASDAQ:ACCD) and maintained a $14 price target.
The news of Morgan Stanley reiterating an Equal-Weight rating on Accolade and maintaining a $14 price target is neutral for the stock price in the short term. The rating suggests that the analyst believes the stock is fairly valued and does not expect significant price movement.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100